Ico Therapeutics Inc (ICO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ICO.VN | TTI.VN | DOSE.CN | ||
| Company | Ico Therapeutics Inc | Thiogenesis Therapeutics Corp | Rapid Dose Therapeutics Corp. | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX Venture | CNSX | ||
| Open | 0.105 | 0.480 | 0.1250 | ||
| High | 0.110 | 0.490 | 0.1350 | ||
| Low | 0.100 | 0.480 | 0.1200 | ||
| Latest | 0.105 | 0.490 | 0.1200 | ||
| Change | unch | +0.020 | +0.0100 | ||
| % Change | unch | +4.26% | +9.09% | ||
| Volume | 1,309,660 | 25,000 | 35,500 | ||
| 20-Day Average Volume | 4,916,119 | 24,478 | 223,085 | ||
| Previous Close | 0.105 | 0.470 | 0.1100 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.107 | 0.500 | 0.1065 | ||
| 20-Day Raw Stochastic | 35.29% | 33.33% | 66.67% | ||
| 20-Day Relative Strength | 53.11 | 44.58 | 49.95 | ||
| Weighted Alpha | +181.87 | -32.97 | -44.54 | ||
| Today's Opinion | 88% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 88% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 03/12/21 | +11.36% since 03/24/26 | +26.32% since 03/25/26 | ||
| Low | 0.100 on 03/19/21 | 0.450 on 03/25/26 | 0.1000 on 03/26/26 | ||
| High | 0.145 on 03/16/21 | 0.495 on 03/25/26 | 0.1350 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +31.25% since 02/19/21 | -9.26% since 02/27/26 | -20.00% since 02/27/26 | ||
| Low | 0.075 on 02/23/21 | 0.440 on 03/24/26 | 0.0900 on 03/24/26 | ||
| High | 0.160 on 02/25/21 | 0.590 on 03/10/26 | 0.1600 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +133.33% since 12/18/20 | -10.91% since 12/24/25 | -7.69% since 12/31/25 | ||
| Low | 0.050 on 01/18/21 | 0.440 on 03/24/26 | 0.0900 on 03/24/26 | ||
| High | 0.160 on 02/25/21 | 0.660 on 01/06/26 | 0.1750 on 02/11/26 | ||
| 6-Month | |||||
| %Chg | +133.33% since 09/18/20 | -30.99% since 09/26/25 | -29.41% since 10/01/25 | ||
| Low | 0.040 on 12/02/20 | 0.440 on 03/24/26 | 0.0900 on 03/24/26 | ||
| High | 0.160 on 02/25/21 | 0.810 on 11/03/25 | 0.1900 on 11/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,036 | 25,400 | 14,830 | ||
| Shares Outstanding, K | 9,065 | 51,836 | 134,819 | ||
| Annual Sales | 0 | 0 | 2,085,176 | ||
| Annual Net Income | -1,488,207 | -3,145,730 | -5,404,265 | ||
| Last Quarter Sales | 0 | 0 | 657,135 | ||
| Last Quarter Net Income | -771,643 | -2,383,961 | -1,140,514 | ||
| 60-Month Beta | 2.18 | -0.05 | -2.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 | -0.05 on 11/26/25 | -0.01 on 01/29/26 | ||
| Latest Earnings Date | 08/30/21 | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||